KORLYM Trademark

Trademark Overview

On Tuesday, July 21, 2015, a trademark application was filed for KORLYM with the United States Patent and Trademark Office. The USPTO has given the KORLYM trademark a serial number of 86699675. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2019. This trademark is owned by CORCEPT THERAPEUTICS, INC.. The KORLYM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
korlym

General Information

Serial Number86699675
Word MarkKORLYM
Filing DateTuesday, July 21, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCORCEPT THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameCORCEPT THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 92626

Trademark Events

Event DateEvent Description
Monday, March 11, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 3, 2018EXTENSION 5 GRANTED
Friday, July 27, 2018EXTENSION 5 FILED
Friday, August 3, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 27, 2018TEAS EXTENSION RECEIVED
Saturday, February 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2018EXTENSION 4 GRANTED
Thursday, February 1, 2018EXTENSION 4 FILED
Thursday, February 1, 2018TEAS EXTENSION RECEIVED
Friday, August 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2017EXTENSION 3 GRANTED
Wednesday, August 2, 2017EXTENSION 3 FILED
Wednesday, August 2, 2017TEAS EXTENSION RECEIVED
Saturday, February 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2017EXTENSION 2 GRANTED
Thursday, February 2, 2017EXTENSION 2 FILED
Thursday, February 2, 2017TEAS EXTENSION RECEIVED
Wednesday, July 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2016EXTENSION 1 GRANTED
Monday, July 25, 2016EXTENSION 1 FILED
Monday, July 25, 2016TEAS EXTENSION RECEIVED
Friday, March 4, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 4, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 30, 2015ASSIGNED TO EXAMINER
Monday, July 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 24, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

korlym ophthalmic gastroenterologic diseases disorders cardiovascular metabolic preparations treatment oncologic pharmaceutical